DocGo Inc. (DCGO) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
DocGo Inc. (DCGO) trades at $0.4345 with AI Score 19/100 (Grade F). DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom. Market cap: $42.9M, Sector: Healthcare.
Price as of Aug 22, 2026 · Last analyzed: May 10, 2026Analyst Coverage for DCGO: DCGO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DCGO against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
DCGO: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
DocGo Inc. (DCGO) Healthcare & Pipeline Overview
DocGo Inc. delivers mobile health and medical transportation services, leveraging a technology-driven platform for at-home and event-based healthcare. Operating in the U.S. and UK, DocGo distinguishes itself through its integrated approach to on-demand medical services, addressing the growing need for accessible and convenient healthcare solutions.
What Is the Investment Thesis for DCGO?
DocGo Inc. presents a compelling investment case centered on its innovative mobile health platform and expanding market presence. The company's focus on delivering healthcare services directly to patients addresses a growing need for accessible and convenient care. Key value drivers include the expansion of its mobile health services, strategic partnerships with healthcare providers, and potential for geographic expansion. However, the company's negative profit margin of -56.6% raises concerns about profitability. Growth catalysts include increasing adoption of telehealth and remote patient monitoring, as well as the continued demand for COVID-19 testing and event-based healthcare services. Investors should monitor the company's ability to improve its financial performance and capitalize on its growth opportunities.
Based on FMP financials and quantitative analysis
DCGO Key Highlights
DocGo operates in the mobile health and medical transportation sector, providing services in the US and UK.
- The company's platform offers a range of services, including emergency response, non-emergency transport, at-home healthcare, and COVID-19 testing.
- DocGo's gross margin stands at 30.7%.
- DocGo's market capitalization is $0.07 billion.
- DocGo has a beta of 0.98, indicating market-correlated volatility.
Who Are DCGO's Competitors?
DCGO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.4M | 63 |
| NVLPF Nova Leap Health Corp. | $0.36 | +5.30% | $31.4M | 55 |
| BTMD biote Corp. | $1.61 | +8.78% | $71.0M | 67 |
| JYNT The Joint Corp. | $8.44 | +2.30% | $120M | 75 |
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.4M | 52 |
| HWAIF Healwell AI Inc. | $0.57 | -0.05% | $171M | 65 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| KJFI Comjoyful International Company | $0.97 | +0.00% | $212M | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DCGO's Key Strengths?
Innovative mobile health platform.
- Integrated service offerings.
- Experienced management team.
- Scalable business model.
What Are DCGO's Weaknesses?
Negative profit margin.
- Limited brand recognition.
- Dependence on key contracts.
- Geographic concentration.
What Could Drive DCGO Stock Higher?
Expansion of mobile health services into new geographic markets.
- Strategic partnerships with hospitals and healthcare systems to integrate DocGo's platform.
- Potential regulatory changes favoring mobile healthcare solutions.
- Increased adoption of telehealth and remote patient monitoring.
What Are the Key Risks for DCGO?
Financial-distress signal — its Altman Z-Score of -2.49 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-89.0%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.
- Intense competition from established healthcare providers and telehealth companies.
- Regulatory changes that could impact the company's operations.
- Economic downturn affecting healthcare spending.
- Technological disruptions that could render the company's platform obsolete.
What Are the Growth Opportunities for DCGO?
- Expansion of Mobile Health Services: DocGo can expand its mobile health services beyond its current offerings to include chronic disease management, remote patient monitoring, and virtual consultations. The market for remote patient monitoring is projected to reach $178.1 billion by 2032, presenting a significant growth opportunity for DocGo. By leveraging its existing platform and network of medical professionals, DocGo can capture a share of this growing market.
- Strategic Partnerships with Healthcare Providers: DocGo can form strategic partnerships with hospitals, clinics, and other healthcare providers to expand its reach and service offerings. These partnerships can provide DocGo with access to new patient populations and referral networks. By collaborating with established healthcare providers, DocGo can enhance its credibility and market position.
- Geographic Expansion: DocGo can expand its operations to new geographic markets, both within the United States and internationally. The company's mobile health platform is scalable and can be adapted to meet the needs of different regions. By expanding its geographic footprint, DocGo can increase its revenue and market share.
- Increased Focus on Value-Based Care: DocGo can align its services with value-based care models, which emphasize patient outcomes and cost-effectiveness. By demonstrating the value of its mobile health services, DocGo can attract payers and providers who are seeking to improve healthcare quality and reduce costs. This shift towards value-based care presents a significant opportunity for DocGo to differentiate itself from its competitors.
- Leveraging Data Analytics: DocGo can leverage data analytics to improve its operational efficiency, personalize patient care, and identify new business opportunities. By analyzing data from its mobile health platform, DocGo can gain insights into patient needs, optimize resource allocation, and develop new services that meet the evolving demands of the healthcare market. This data-driven approach can help DocGo to enhance its competitive advantage and drive sustainable growth.
What Are DCGO's Competitive Advantages?
- Proprietary mobile health platform.
- Established network of medical professionals.
- Integrated approach to mobile healthcare delivery.
- Scalable business model.
What Does DCGO Do?
DocGo Inc., established in 2015 and headquartered in New York City, operates as a mobile health and medical transportation provider, serving healthcare providers across the United States and the United Kingdom. The company's core business revolves around delivering healthcare services directly to patients through its mobile platform. These services encompass a broad spectrum, including emergency response, non-emergency medical transport via ambulance and wheelchair, at-home and office healthcare, COVID-19 testing, and on-site healthcare support for events such as sporting events and concerts. DocGo's integrated approach aims to improve healthcare accessibility and convenience, particularly in underserved areas or situations where traditional healthcare settings are less practical. By leveraging technology and a network of medical professionals, DocGo seeks to streamline healthcare delivery and enhance patient outcomes. The company's focus on mobile health positions it to capitalize on the increasing demand for remote and personalized healthcare solutions.
What Products and Services Does DCGO Offer?
- Provides mobile health services directly to patients.
- Offers emergency response services.
- Provides non-emergency medical transportation via ambulance and wheelchair.
- Delivers at-home and office healthcare services.
- Conducts COVID-19 testing.
- Offers on-site healthcare support for events.
How Does DCGO Make Money?
- Generates revenue through fees for mobile health services.
- Charges for medical transportation services.
- Contracts with healthcare providers for mobile healthcare solutions.
- Provides event-based healthcare services on a contract basis.
What Industry Does DCGO Operate In?
DocGo operates within the rapidly evolving healthcare industry, where mobile health and telehealth solutions are gaining traction. The market for mobile health is projected to reach significant growth in the coming years, driven by factors such as increasing adoption of smartphones, rising healthcare costs, and a growing need for remote patient monitoring. DocGo's competitive landscape includes traditional healthcare providers, telehealth companies, and medical transportation services. The company's focus on integrated mobile health services positions it to capitalize on the industry's growth potential.
Who Are DCGO's Key Customers?
- Healthcare providers seeking to expand their reach and service offerings.
- Patients in need of convenient and accessible healthcare services.
- Organizations requiring on-site healthcare support for events.
- Individuals seeking COVID-19 testing.
DocGo Inc. Financial Trajectory
DocGo Inc. (DCGO) reported $73.42T in revenue for Q2 2026, reflecting 97186198.6% growth compared to the prior quarter. The company recorded a net loss of $15.82T, with diluted EPS of $-0.16. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Healthcare company. Across the four most recent quarters, DCGO averaged $-0.49 in diluted EPS.
Company Profile
DocGo Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in New York City, US. The company is led by CEO Lee Bienstock. DCGO has traded publicly since 2020.
How DocGo Inc. Is Valued
DocGo Inc. carries a market capitalization of $42.9M, placing it in the micro-cap category. Relative to its peer group, DCGO's quantitative score of 19/100 is below the peer average of 62/100.
Key Financial Metrics
Return on equity for DocGo Inc. stands at -89.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -89.7%, showing how much profit it generates from its asset base. A current ratio of 1.79 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
DocGo Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -2.49 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
DocGo Inc. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 274.7% below estimates on average.
Forward Outlook
Wall Street analysts project DocGo Inc. revenue of about $306.3M for fiscal 2026, with EPS near $-0.51. The estimate reflects 3 contributing analysts.
DCGO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Innovative mobile health platform.
- Integrated service offerings.
- Experienced management team.
- Scalable business model.
Bear Case
- Negative profit margin.
- Limited brand recognition.
- Dependence on key contracts.
- Geographic concentration.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $73424.72B | -$15820.28B | -$0.16 |
| Q1 2026 | $76M | -$15M | -$0.15 |
| Q4 2025 | $75M | -$134M | -$1.37 |
| Q3 2025 | $71M | -$28M | -$0.28 |
Based on FMP financials and quantitative analysis
DCGO Latest News
-
12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga · Aug 12, 2026
DCGO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DCGO.
Price Targets
Wall Street price target analysis for DCGO.
DCGO MoonshotScore
What does this score mean?
The MoonshotScore rates DCGO 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Lee Bienstock
CEO
Lee Bienstock serves as the CEO of DocGo, bringing extensive experience in healthcare management and technology. His background includes leadership roles in various healthcare organizations, where he focused on improving operational efficiency and patient outcomes. Bienstock's expertise spans strategic planning, business development, and technology implementation. He holds degrees in business administration and healthcare management, providing him with a strong foundation for leading DocGo's growth and innovation.
Track Record: Under Lee Bienstock's leadership, DocGo has expanded its mobile health services and strengthened its partnerships with healthcare providers. He has overseen the company's growth in new geographic markets and the development of innovative healthcare solutions. Bienstock's strategic decisions have contributed to DocGo's position as a leader in the mobile health industry.
DocGo Inc. Healthcare Stock: Key Questions Answered
What does the AI Score mean for DCGO?
DCGO holds an AI Score of 19/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom. Their platform offers at-home and office healthcare, COVID-19 testing, and event …
What does DocGo Inc. do?
DocGo Inc. operates as a mobile health and medical transportation provider, offering a range of services directly to patients in the United States and the United Kingdom. The company's core business revolves around delivering healthcare services through its mobile platform, including emergency response, non-emergency medical transport, at-home and office healthcare, COVID-19 testing, and on-site healthcare support for events.
What do analysts say about DCGO stock?
Analyst coverage of DocGo Inc. is limited, but existing reports suggest a mixed outlook. Some analysts highlight the company's growth potential in the mobile health market, while others express concerns about its profitability and competitive landscape. Valuation metrics vary depending on the analyst's assumptions, but key considerations include the company's revenue growth, gross margin, and ability to achieve profitability.
What are the main risks for DCGO?
DocGo Inc. faces several risks, including intense competition from established healthcare providers and telehealth companies, regulatory changes that could impact its operations, and economic downturn affecting healthcare spending. The company's negative profit margin also poses a risk, as it needs to improve its financial performance to sustain its growth. Additionally, technological disruptions could render the company's platform obsolete, requiring continuous innovation and adaptation.
What are the key factors to evaluate for DCGO?
DocGo Inc. (DCGO) holds an AI score of 19/100 (low). presents a compelling investment case centered on its innovative mobile health platform and expanding market presence. Not financial advice.
How frequently does DCGO data refresh on this page?
DCGO's price was last updated on Aug 22, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven DCGO's recent stock price performance?
DocGo Inc. (DCGO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative mobile health platform. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DCGO overvalued or undervalued right now?
DocGo Inc. (DCGO) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research DCGO before investing?
Before investing in DocGo Inc. (DCGO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial data is based on the most recent reports and may not be fully up-to-date.